RecruitingHypertrophic Cardiomyopathy
VIZ ACCESS HCM - Multi-Site Registry
Eligible age
18+ yrs
Accepts
All genders
Locations
3 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.
Sponsor: Viz.ai, Inc.
Where it's recruiting
Source: ClinicalTrials.gov · NCT07103057 · last updated 2025-08-17